This two-part webinar series explores recent developments in oligonucleotide chemistry, biology, DMPK, toxicological assessment, manufacture, and formulation.
Part 2: Oligonucleotide Drug Development (CMC)
* Explore synthesis strategies and analytical methodologies
* Compare the advantages and disadvantages of different formulation strategies
* Review the latest CMC strategies and regulatory framework
